Repronovo starts EU phase 2 trial of NORDIC for embryo implantation: Lausanne, Switzerland Tuesday, July 7, 2026, 18:00 Hrs [IST] ReproNovo, a clinical-stage biopharmaceutical com ...
Vande Bharatam, an initiative by Gautam Adani to spur innovators in pharma and healthcare: Our Bureau, Bengaluru Tuesday, July 7, 2026, 17:45 Hrs [IST] Vande Bharatam, a nationwid ...
DRI seizes 1.11 lakh codeine syrup bottles in a major crackdown on drug trafficking: Our Bureau, Mumbai Tuesday, July 7, 2026, 16:20 Hrs [IST] Continuing its sustained efforts to ...
DSS Takara Bio India marks 15 years of powering India’s molecular biology revolution: Our Bureau, Bengaluru Tuesday, July 7, 2026, 17:15 Hrs [IST] DSS Takara Bio India. (DTI), t ...
Invivyd receives advanced notice of EUA termination for Pemgarda in US: New Haven, Connecticut Tuesday, July 7, 2026, 17:00 Hrs [IST] Invivyd, Inc., announced that the US Food and ...
The Maharashtra Food and Drugs Administration (FDA) has issued immediate recall of unsafe cosmetics from the market after FDA lab government analyst tests declared three cosmetic products as Not of ...
Omnigel launches Omnigel Maxstrong; marks its entry into long-lasting relief: Our Bureau, Mumbai Tuesday, July 7, 2026, 16:50 Hrs [IST] Omnigel, Cipla Health’s leading pain reli ...
Astex signs research collaboration and license agreement with Genentech for breast cancer therapy: Cambridge, UK Tuesday, July 7, 2026, 16:00 Hrs [IST] Astex Pharmaceuticals, a wh ...
Granules India secures FTF status for sodium oxybate ER for oral suspension: Our Bureau, Mumbai Tuesday, July 7, 2026, 15:45 Hrs [IST] Granules India Limited announced that it has ...
MedRabbits Clinic Expands into Maritime Healthcare with DG Shipping Certification: Our Bureau, Bengaluru Tuesday, July 7, 2026, 16:40 Hrs [IST] MedRabbits Clinic, the integrated h ...
FOPE seeks clarity from CDSCO on Pharmacovigilance as per Para 6.11 of Revised Schedule M & NDCT Rules, 2019: Nandita Vijayasimha, Bengaluru Tuesday, July 7, 2026, 08:00 Hrs [IST] ...
CDSCO calls for stakeholder comments on use of same brand name with different extensions for multiple formulations: Our Bureau, New Delhi Tuesday, July 7, 2026, 14:20 Hrs [IST] Th ...